文献速递系统性红斑狼疮

狼疮肾炎临床试验替代肾脏终点:预测长期肾脏结局新方法的开发与验证

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.
PubMed 文献 · Arthritis Rheumatol · 2019-02-01

研究基于3项临床试验和12个纵向队列的944例狼疮肾炎(LN)患者数据库,评估诊断后12个月内变量对36个月随访期长期肾脏结局的预测价值。在550例合格受试者中发生54例慢性肾脏病(CKD)、55例严重肾损伤(SKI)和22例需永久肾脏替代治疗(RRT)事件;基于Cox回归构建的风险指数工具(HITs)内部验证c指数0.84-0.92,独立队列验证c指数0.89-0.92。结论认为基于短期肾脏治疗反应的HITs与长期肾脏结局相关,需进一步验证作为LN临床试验替代终点。

要点

  • 基于12个月短期变量的HITs可预测36个月CKD、SKI和RRT结局。
  • CKD HIT包含预测期CKD状态、12个月蛋白尿和12个月血肌酐。
  • HITs内部验证c指数0.84-0.92,独立队列验证c指数0.89-0.92。

核心结论

  • 基于短期肾脏治疗反应构建的HITs与长期肾脏结局相关,需进一步验证作为LN临床试验替代终点。

研究设计与样本

  • 数据库由3项临床试验和12个纵向队列的944例LN患者组成,评估诊断后12个月内变量对36个月随访期长期结局的预测价值。
  • 长期结局包括新发或进展性CKD、SKI和需永久RRT,采用Cox比例风险回归多变量分析构建HITs。
  • 550例合格受试者中发生54例CKD、55例SKI和22例RRT事件。

主要发现

  • CKD HIT最终变量为预测期CKD状态、12个月蛋白尿和12个月血肌酐水平。
  • SKI HIT变量包括预测期CKD状态、ISN/RPS分型、12个月蛋白尿、12个月血肌酐、种族及ISN/RPS分型与12个月蛋白尿的交互作用。
  • RRT HIT包括诊断时年龄、12个月蛋白尿和12个月血肌酐水平。
  • 各HIT内部验证c指数0.84-0.92,独立LN队列验证c指数0.89-0.92。

临床怎么用

  • 短期(12个月)肾脏反应指标可用于评估LN患者长期CKD、SKI和RRT风险,辅助临床试验终点设计。

局限性

  • HITs需进一步验证作为LN临床试验替代终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: End points currently used in lupus nephritis (LN) clinical trials lack uniformity and questionably reflect long-term kidney survival. This study was undertaken to identify short-term end points that predict long-term kidney outcomes for use in clinical trials. METHODS: A database of 944 patients with LN was assembled from 3 clinical trials and 12 longitudinal cohorts. Variables from the first 12 months of treatment after diagnosis of active LN (prediction period) were assessed as potential predictors of long-term outcomes in a 36-month follow-up period. The long-term outcomes examined were new or progressive chronic kidney disease (CKD), severe kidney injury (SKI), and the need for permanent renal replacement therapy (RRT). To predict the risk for each outcome, hazard index tools (HITs) were derived using multivariable analysis with Cox proportional hazards regression. RESULTS: Among 550 eligible subjects, 54 CKD, 55 SKI, and 22 RRT events occurred. Variables in the final CKD HIT were prediction-period CKD status, 12-month proteinuria, and 12-month serum creatinine level. The SKI HIT variables included prediction-period CKD status, International Society of Nephrology (ISN)/Renal Pathology Society (RPS) class, 12-month proteinuria, 12-month serum creatinine level, race, and an interaction between ISN/RPS class and 12-month proteinuria. The RRT HIT included age at diagnosis, 12-month proteinuria, and 12-month serum creatinine level. Each HIT validated well internally (c-indices 0.84-0.92) and in an independent LN cohort (c-indices 0.89-0.92). CONCLUSION: HITs, derived from short-term kidney responses to treatment, correlate with long-term kidney outcomes, and now must be validated as surrogate end points for LN clinical trials.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Mackay M, Dall'Era M, Fishbein J, et al. Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes. Arthritis Rheumatol. 2019. PMID: 30225865. doi:10.1002/art.40724

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。